Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV6H9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,758
Award facts
- Contract value 100% obligated
- $48,758.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Cosentyx (secukinumab) 300 mg pen 2 ml injections valued at $48,758.06 with a firm fixed price structure. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Cosentyx is a specialty biologic medication used primarily to treat autoimmune conditions including psoriasis, rheumatoid arthritis, and ankylosing spondylitis. The delivery order fulfills the Defense Health Agency's medical supply requirements through AmerisourceBergen's established capacity as a critical federal pharmaceutical vendor. The company's extensive portfolio demonstrates consistent competitiveness in federal medical procurement, with the DLA Medical Supply Chain relying on AmerisourceBergen to distribute a broad range of branded and generic pharmaceuticals, vaccines, and specialized medical supplies to support military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FV6H9?
SPE2DR26FV6H9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FV6H9 worth?
The government has obligated $48,758 on SPE2DR26FV6H9.
Is contract SPE2DR26FV6H9 an order under another contract?
Yes. SPE2DR26FV6H9 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6H9 competed?
The extent of competition for SPE2DR26FV6H9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award